COM:CARIBOUBIO
Caribou Biosciences
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalswebsite
cariboubio.comcrunchbase
caribou-biosciences/linkedin
caribou-biosciencesfounding date
Jan 01, 2011ipo date
Jul 23, 2021
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed...Show More